Citigroup Maintains Buy on Exact Sciences, Announces $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Patrick Donnelly maintains a Buy rating on Exact Sciences (NASDAQ:EXAS) and sets a price target of $100.

April 03, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Exact Sciences and sets a price target of $100.
The reiteration of a Buy rating and the setting of a $100 price target by a major financial institution like Citigroup suggests a strong bullish outlook on Exact Sciences. This endorsement is likely to instill confidence in investors about the company's future prospects, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100